The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia

• Yun Zhou,
• Haiwei Lian,
• Ning Shen,
• Sovannarith Korm,
• Andrew Kwok Ping Lam,
• Olivia Layton,
• Leah N. Huiting,
• Dun Li,
• Kelly Miao,
• Aozhuo Zeng,
• Esther Landesman-Bollag,
• David C. Seldin,
• Hui Fu,
• Li Hong,
• Hui Feng

Affiliations

Yun Zhou

Department of Gynecology, Wuhan University Renmin Hospital, Wuhan, Hubei, P. R. China;

Haiwei Lian

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Ning Shen

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Sovannarith Korm

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Andrew Kwok Ping Lam

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Olivia Layton

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Leah N. Huiting

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Dun Li

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Kelly Miao

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Aozhuo Zeng

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;

Esther Landesman-Bollag

Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA;

David C. Seldin

Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA;

Hui Fu

Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, Wuhan, Hubei, P. R. China;

Li Hong

Department of Gynecology, Wuhan University Renmin Hospital, Wuhan, Hubei, P. R. China;

Hui Feng

Department of Pharmacology and Experimental Therapeutics, Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA